ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Regístrate

¿Ya eres miembro? Iniciar sesión

Los Principales Corredores en Línea

Más Corredores en Línea

Datos
Noticias
Herramientas
Mercados
Descubrir

Hot Features

Follow Feed

Conéctese con traders e inversores en nuestra comunidad Follow Feed.

Flujo de Opciones

Explora datos de opciones completos y utiliza filtros avanzados con Options Flow.

Monitor

Organiza y monitorea tu lista de seguimiento de acciones y activos con Monitor.
Iniciar Sesión Premium IconPremium Help Menu
S&P 500
5,893.62
0.39%
Dow Jones
43,389.60
-0.13%
US Dollar vs MXN
20.2154
0.00%
Brent Oil
72.935
0.00%
Bitcoin
90,535.14
0.01%
Registration Strip Icon for alerts Regístrate para obtener alertas en tiempo real, cartera personalizada y movimientos del mercado.
Regístrate
  1. Inicio
  2. Invertir
  3. Acciones
  4. Europa
  5. EU

  6. Vivoryon Therapeut (VVY) Cotización

Vivoryon Therapeut

Vivoryon Therapeut (VVY)

EU
2.05
0.02
(0.99%)
Cerrado 18 Noviembre 10:30AM
Delayed by 15 minutes

Su centro para precios en tiempo real, ideas y debates en vivo

Premium

Estadísticas y detalles clave

Último Precio
2.05
Postura de Compra
2.00
Postura de Venta
2.10
Volume Operado de la Acción
85,189
2.005 Rango del Día 2.075
0.41 Rango de 52 semanas 9.93
Capitalización de Mercado [m]
-
Precio Anterior
2.03
Precio de Apertura
2.005
Hora
430
@
2.05
Última hora de negociación
Volumen financiero
-
Precio Promedio Ponderado
-
Volumen promedio (3 m)
186,544
Acciones en circulación
0.00
Rendimiento del Dividendo
-
Ratio Precio/Utilidad
0.00
Beneficio por acción (BPA)
-
turnover
-3.62M
Beneficio neto
-28.34M

Acerca de Vivoryon Therapeut

Sector
Biological Pds,ex Diagnstics
Industria
Biological Pds,ex Diagnstics
Sitio web
www.vivoryon.com
Sede
Halle, Deu
Fundado
-
Vivoryon Therapeut is listed in the Biological Pds,ex Diagnstics sector of the Euronext with ticker VVY. The last closing price for Vivoryon Therapeut was 2.03 €. Over the last year, Vivoryon Therapeut shares have traded in a share price range of 0.41 € to 9.93 €.

Vivoryon Therapeut currently has 0 shares in issue.

VVY Últimas noticias

Más noticias

Vivoryon Therapeutics N.V. Presents Outstanding Phase 2b Results of Varoglutamstat on Kidney Function at ASN Kidney Week 2024

Vivoryon Therapeutics N.V. Presents Outstanding Phase 2b Results of Varoglutamstat on Kidney Function at ASN Kidney Week 2024 Vivoryon Therapeutics N.V. Presents Outstanding Phase 2b Results of...

26 Octubre 2024
UK Regulatory

Vivoryon Therapeutics N.V. Announces Late-breaking Oral Presentation at the American Society of Nephrology Kidney Week 2024

Vivoryon Therapeutics N.V. Announces Late-breaking Oral Presentation at the American Society of Nephrology Kidney Week 2024 Halle (Saale) / Munich, Germany, October 11, 2024 – Vivoryon...

11 Octubre 2024
UK Regulatory

Vivoryon Therapeutics N.V. Shares Highlights from Virtual Kidney Disease KOL Event

Vivoryon Therapeutics N.V. Shares Highlights from Virtual Kidney Disease KOL Event Halle (Saale) / Munich, Germany, October 1, 2024 – Vivoryon Therapeutics N.V. (Euronext Amsterdam: VVY;...

01 Octubre 2024
UK Regulatory

Vivoryon Therapeutics N.V. Reports H1 2024 Progress Marked by Compelling Kidney Function Data and Execution of Strategy to Advance Varoglutamstat in Kidney Disease

Vivoryon Therapeutics N.V. Reports H1 2024 Progress Marked by Compelling Kidney Function Data and Execution of Strategy to Advance Varoglutamstat in Kidney Disease Vivoryon Therapeutics N.V...

12 Septiembre 2024
UK Regulatory

Vivoryon Therapeutics N.V. Announces Completion of Share Capital Reduction and Change to Articles of Association

Vivoryon Therapeutics N.V. Announces Completion of Share Capital Reduction and Change to Articles of Association Vivoryon Therapeutics N.V. Announces Completion of Share Capital Reduction and...

05 Septiembre 2024
UK Regulatory

Vivoryon Therapeutics N.V. to Report Half Year 2024 Financial Results on September 12, and to Host KOL Event on September 30, 2024

Vivoryon Therapeutics N.V. to Report Half Year 2024 Financial Results on September 12, and to Host KOL Event on September 30, 2024 Vivoryon Therapeutics N.V. to Report Half Year 2024 Financial...

05 Septiembre 2024
UK Regulatory

Vivoryon Therapeutics N.V. Announces New Data Showing Unique Treatment Effects of Varoglutamstat on Kidney Function in Patients with Diabetes and Outlines Proposed Clinical Development Plan in Diabetic Kidney Disease

Vivoryon Therapeutics N.V. Announces New Data Showing Unique Treatment Effects of Varoglutamstat on Kidney Function in Patients with Diabetes and Outlines Proposed Clinical Development Plan in...

18 Julio 2024
UK Regulatory

Vivoryon Therapeutics N.V. to Host R&D Update Call on July 18, 2024 Focused on Progress in Kidney Disease

Vivoryon Therapeutics N.V. to Host R&D Update Call on July 18, 2024 Focused on Progress in Kidney Disease Vivoryon Therapeutics N.V. to Host R&D Update Call on July 18, 2024 Focused on...

09 Julio 2024
UK Regulatory

Vivoryon Therapeutics N.V. to Host R&D Update Call on July 18, 2024 Focused on Progress in Kidney Disease

Vivoryon Therapeutics N.V. to Host R&D Update Call on July 18, 2024 Focused on Progress in Kidney Disease Halle (Saale) / Munich, Germany, July 9, 2024 - Vivoryon Therapeutics N.V. (Euronext...

09 Julio 2024
GlobeNewswire Inc.

Vivoryon Therapeutics N.V. Reports Outcome of 2024 Annual General Meeting

Vivoryon Therapeutics N.V. Reports Outcome of 2024 Annual General Meeting Vivoryon Therapeutics N.V. Reports Outcome of 2024 Annual General Meeting Halle (Saale) / Munich, Germany, June 21...

21 Junio 2024
GlobeNewswire Inc.
Período †Variación(Ptos)Variación %AperturaPrecio MáximoPrecio MínimoAvg. Vol. diarioPrecio Promedio Ponderado
1-0.155-7.029478458052.2052.242.005734522.0944024DE
4-0.34-14.22594142262.392.592.0051335942.32869083DE
12-0.17-7.657657657662.222.9951.8241865442.3276004DE
261.248155.6109725690.8026.30.786322622.4738679DE
52-5.75-73.71794871797.89.930.415406432.06117631DE
156-16.7-89.066666666718.7520.6350.412205243.93028214DE
260-3.15-60.57692307695.223.250.411707885.17776562DE

Movimientos

Ver todo
  • Volumen
  • % Mayores Alzas
  • % Mayores Bajas
SímboloPrecioVol.
MHMMyHotelMatch
0.598 €
(71.84%)
72.21k
CNVCnova NV
1.125 €
(60.71%)
14.78k
EMGDSEuromedis DS
0.015 €
(36.36%)
11.96k
MLNMAMiguet Et Associes
0.0995 €
(24.38%)
650
EBUSEbusco Holding NV
1.51 €
(19.27%)
944.29k
EBUSREbusco
0.0003 €
(-99.81%)
6.18M
MLONEBody One
0.24 €
(-25.00%)
3.18k
ALSPWSpineway
0.1066 €
(-18.00%)
2.22M
HYLHyloris Pharmaceuticals SA
3.30 €
(-17.50%)
51k
ALVERVergnet
0.0049 €
(-15.52%)
9.6M
ALNEVNeovacs
0.0002 €
(0.00%)
43.54M
BCPBanco Comercial Portugues SA
0.4476 €
(0.65%)
24.98M
ALHPIHopium SA
0.0098 €
(-2.00%)
19.79M
ALCYBCybergun
0.0001 €
(0.00%)
12.96M
ALVERVergnet
0.0049 €
(-15.52%)
9.6M

Discusión

Ver feed completo
maumar maumar 4 minutos hace
Agreed. And if we are borrowing about $1.5B at 7%, we are adding over $100M in yearly interest payments. But I do think an acquisition is necessary to diversify and extend the durability of their revenues. According to Halo's own projections, revenue growth slows down to barely 5% in 2028 so they co
HALO
crazy horse 0 crazy horse 0 5 minutos hace
Revoke this criminal

https://scontent-mia3-2.xx.fbcdn.net/v/t39.30808-6/467400598_10232092508588433_1930355040431644447_n.jpg?_nc_cat=109&ccb=1-7&_nc_sid=aa7b47&_nc_ohc=JoIzGEupZl4Q7kNvgHpP1RS&_nc_zt=23&_nc_ht=scontent-mia3-2.xx&_nc_gid=AjG2Zz-8lOXk0HDjqHcDKdz&oh=00_AYC2PS6KYrrUJoDu3U
FeMike FeMike 5 minutos hace
Good thinking Gary. I’ll have to check what my gain is for the year cause I haven’t sold much, but should have at least 5-10k after other losses I’ve already scrubbed.

I’ll take a little 20-40k share flyer hoping it doesn’t drop 30% before year end.
NWBO
koolmc koolmc 6 minutos hace
nice congrats guys
SMCI
trunkmonk trunkmonk 6 minutos hace
It’s worth more.
XRPUSD
fuagf fuagf 6 minutos hace
Once Pence said no. Then enough American voters said no. Then Trump finally conned enough American voters to say yes.
If Gabbard gets to where Putin has likely told Trump he wants her to be the US will be closer to being a client state of Moscow.
cowtown jay cowtown jay 6 minutos hace
Last updated today, with bid and ask prices.

Key stats and details
Current Price
0.0361
Bid
0.0356
Ask
0.0358
Volume
0
0.00
Day's Range
0.00
0.00
52 Week Range
0.00

https:/
Tadaaa Tadaaa 6 minutos hace
Going to bust through .15
HBARUSD
TRIPLE_ZERO_SEVEN TRIPLE_ZERO_SEVEN 6 minutos hace
More buys than sells today I see.
AAPJ
EternalPatience EternalPatience 7 minutos hace
We can be certain that this speech or "too complex to solve", will take years to resolve etc are all just fluff. Ignore...  We are getting someone who will resolve it fast. Paulson + Ackman > media..  they will resolve this in 2025. Ignore the ihub noise as well until then
FNMA
Researchfyi Researchfyi 7 minutos hace
At least they reimbursed you for the cost to explore the product. That’s more than most would do.
LQMT
Golf4Food Golf4Food 8 minutos hace
Can you extrapolate what that may mean in a business sense? Suppose someone hired me to develop a new golf ball but they had no money. Would they offer me shares in their company in the stead? Suppose I had a history of bringing my balls into the mouth of the consumer world. Would you not want to pr
ILST
stockprofitter stockprofitter 8 minutos hace
Here’s a thought - Doubt the government is friendly or favorable to preferred holders after they dragged them through the courts for years and years.
FNMA
Hopeforthefuture3 Hopeforthefuture3 8 minutos hace
Norisk, not at all - just trying to share the facts on tax loss harvesting. I have done so with nwbo several times and always bought back. I'm going on the assumption that most have substantial gains in other stocks and if they choose to take some of the gains they can be offset dollar for dollar an
NWBO
Elroy Jetson Elroy Jetson 8 minutos hace
You need too use social media to excite the thralls into paying you millions for your banana installation.

The world is apparently filled to the brim with followers eager to be fleeced.


Salesman on train: How far are you going friend?

Music Man: W
waterchaser waterchaser 8 minutos hace
Expect a big dump tomorrow.
Welcome to a classic OTC/HIRU/IHUB pump and dump.
https://investorshub.advfn.com/uimage/uploads/2018/9/24/gunnu05397CD6-58DD-41AE-95CE-67A792B6E84B.png
HIRU
rosemountbomber rosemountbomber 8 minutos hace
Yeah, of course a little different in their case. Their delisting not related to be under a buck.
AMRN
CanItBThisEZ2Make CanItBThisEZ2Make 10 minutos hace
ZHUD Deal is Signed ====>
https://investorshub.advfn.com/uimage/uploads/2024/11/18/[ooajScreenshot_20241118-191045~2.png
https://belisarianholdings.com/updates#
GO ZHUD$
ZHUD
santafe2 santafe2 10 minutos hace
They are trying to pay off company debt with other people's money. They are between a rock and a hard place. Today selling at .0003 sellers took in a little over $25,000. I would assume most of that selling was from shares owned by RONN. We can't know because it's a Pink Sheet company and that level
RONN
WhenLambo WhenLambo 11 minutos hace
suppose you're color blind, does color not exist for you? you can't prove color is there through your own experiences or senses, yet it exists
TPTW
Renee Renee 11 minutos hace
Hash Corporation changed to Street Cap Inc

https://otce.finra.org/otce/dailyList?viewType=Symbol%2FName%20Changes
REZNF
Zorax Zorax 12 minutos hace
Why can't even 5 house republicans denounce the party and become democrats and take the house?
Why don't Liz Cheney and Adam Kinzinger dump their party and join the dems? They could go back years later maybe if gop ever finds themselves.
eur06 eur06 12 minutos hace
Still here…was trying to add at 3.26 but nada…they wanted 3.34.
Got enough though thank you dino!
VCNX
VCNX
Roofus Roofus 12 minutos hace
Exactly ….

IDE submission can and should be FDA approved before human trials start any where.
RDGL
Eli's Gone Eli's Gone 12 minutos hace
AL ROY:
Winner: Luis Gil, New York Yankees

Final tally: Gil 106 (15 first-place votes); Colton Cowser, Orioles 101 (13); Austin Wells, Yankees 17; Mason Miller, Athletics 16 (1); Cade Smith, Guardians 12 (1); Wilyer Abreu; Red Sox 11; Wyatt Langford, Rangers 7

NL

Su Consulta Reciente

EU
VVY
Vivoryon Therapeut
NYSE
MEG
Montrose Environmental
BIT
P1R965
BNP Paribas Issuance
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

México
Empresa
Negocios
Popular
Obtener la aplicación
App Store
Google Play

Soporte: (55) 4170 8128 | soporte@advfn.mx

Al acceder a los servicios disponibles de ADVFN usted acepta quedar sujerto a los Términos y Condiciones

© 2024 ADVFN PLC - Todos los derechos reservados